These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1924792)

  • 1. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T.
    Stevens SK; Hricak H; Stern JL
    Radiology; 1991 Nov; 181(2):481-8. PubMed ID: 1924792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
    Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
    Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
    Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
    Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
    Nakahara H; Noguchi S; Murakami N; Tamura S; Jinnouchi S; Kodama T; Adjei ON; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
    Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging.
    Vogl TJ; Pegios W; Mack MG; Hünerbein M; Hintze R; Adler A; Lobbeck H; Hammerstingl R; Wust P; Schlag P; Felix R
    AJR Am J Roentgenol; 1997 Jun; 168(6):1427-34. PubMed ID: 9168702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.
    Hamm B; Thoeni RF; Gould RG; Bernardino ME; Lüning M; Saini S; Mahfouz AE; Taupitz M; Wolf KJ
    Radiology; 1994 Feb; 190(2):417-23. PubMed ID: 8284392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
    Mahfouz AE; Hamm B; Wolf KJ
    Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
    Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
    AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
    Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
    Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
    Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
    Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?
    Hamm B; Mahfouz AE; Taupitz M; Mitchell DG; Nelson R; Halpern E; Speidel A; Wolf KJ; Saini S
    Radiology; 1997 Mar; 202(3):677-82. PubMed ID: 9051015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-enhanced MR imaging of renal masses.
    Rominger MB; Kenney PJ; Morgan DE; Bernreuter WK; Listinsky JJ
    Radiographics; 1992 Nov; 12(6):1097-116; discussion 1117-8. PubMed ID: 1439014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
    De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
    Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.